Is Pharma-Bio Serv, Inc. a good investment? Pharma-Bio Serv, Inc. (PBSV) is currently trading at 0.5700 USD.
Earnings Schedule: Pharma-Bio Serv, Inc. is expected to release its next earnings report on June 15, 2026. The market consensus estimate for Forward EPS is 0.11.
For income investors, Pharma-Bio Serv, Inc. pays a dividend yield of 13.16%. With a payout ratio of -4515%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.08 USD (13.16% yield).
Pharma-Bio Serv, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be June 15, 2026.
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.08 USD
|
| March 22, 2027 (estimated) | 0.0750 |
| ▸2026 |
0.08 USD
|
| March 20, 2026 | 0.0750 |
| ▸2025 |
0.08 USD
|
| March 20, 2025 | 0.0750 |
| ▸2024 |
0.08 USD
|
| Feb. 15, 2024 | 0.0750 |
| ▸2023 |
0.08 USD
|
| April 14, 2023 | 0.0750 |
| ▸2022 |
0.15 USD
|
| March 15, 2022 | 0.0750 |
| Jan. 3, 2022 | 0.0750 |
| ▸2021 |
0.08 USD
|
| Feb. 5, 2021 | 0.0750 |
| ▸2019 |
0.08 USD
|
| Nov. 15, 2019 | 0.0750 |
| ▸2018 |
0.08 USD
|
| Oct. 26, 2018 | 0.0750 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Pharma-Bio Serv, Inc. | Mar 20, 2026 | Paid | 0.075 USD |
Community Discussion